Clinical Trials · NCT04331717

Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer

WithdrawnPhase 2Gonadorelin (Prohibited)
Phase
Phase 2
Recruitment status
Withdrawn
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Enrollment
0
Start date
Nov 2020
Locations
1 site, United States
Primary endpoint
Number of participants who experience at least 5 percent weight loss
View Gonadorelin compound reference